Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

A L Bruce Carter


  • Director at Xencor Inc (XNCR), 2017-06-16
  • Director at Mirati Therapeutics Inc. (MRTX), 2017-05-19
  • Director at Enanta Pharmaceuticals Inc (ENTA), 2017-02-22
  • Director at Regulus Therapeutics Inc. (RGLS), 2015-06-26
  • Director at Qlt Inc (QLTI), 2011-05-28
  • Director at Zymogenetics Inc (ZGEN), 2010-10-12
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaning Holdings Date Form 4
QLTI $2.07 20,000 Director 20,000 2009-05-14 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
XNCR $20.63 302 Director 48,578 2017-06-14 Filing
XNCR $20.61 19,698 Director 48,880 2017-06-14 Filing
XNCR $22.00 2,366 Director 68,578 2017-06-02 Filing
XNCR $22.04 882 Director 70,944 2017-05-26 Filing
XNCR $22.21 11,518 Director 71,826 2017-05-26 Filing